News
Press Kit-
Biopharma Dive
Immunotherapy advances spur new look at cancer vaccines
-
Targeted Oncology
Research Shows Growing Attention Toward Gut Microbiome's Role in Immunotherapy Response
-
AXIOS
Getting personal: Breast cancer treatment
-
APBN
Reprogramming the immune system against cancer
-
PICI
Colorectal cancer genetics study sheds light on why some patients are resistant to treatment
-
PICI
Parker Institute for Cancer Immunotherapy Scientists Present at ASCO 2018 on Gene Editing in Cell Therapy, Novel Checkpoint Inhibitor Combinations and Other Advances in Immuno-Oncology
-
Fortune
Q&A: Sean Parker on Napster, Spotify, and His Federal Tax Law Triumph
-
New York Times
Using Medicine and Science to Improve the Quality of Life
-
Nature
How gut microbes are joining the fight against cancer
-
Endpoints News
Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback
-
Modern Pathology
Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin
-
Town and Country
Meet T&C's Top 50 Philanthropists of 2018
-
Let's Win!
Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1
-
Let's Win! Pancreatic Cancer
Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1
-
Stanford Medicine News Center
Mackall awarded $11.9 million for anti-leukemia clinical trial
-
genomeweb
CytoReason's Machine-Learning Model Offers New Insights Into Immune-Related Diseases
-
PICI website
Parker Institute Picks from AACR 2018 #PICIPicks
-
PICI website
Next Generation of Leaders Gather for Knowledge Exchange in Cancer Immunotherapy Research
-
TIME Magazine
Carl June: Time 100
-
Endpoint News
Former Novo chairman Göran Ando joins the board as Tessa bags $50M in additional funding